The paper lists the correct method of diagnosing chronic pain, and matching the proper medication to tissue damage without the use of narcotics or opioids.
- This interim analysis of an ongoing observational study found that topical analgesics may reduce pain severity and interference scores and decrease primary pain complaints and oral pain medication use for patients with neuropathic or musculoskeletal pain.
- Overall patient satisfaction with topical analgesics was high and they were found to be safe and well-tolerated.
- The results were consistent with a previous interim analysis and warrant continuation of the larger OPERA study, though more analysis is still needed.
The conundrum of opioid tapering in long term opioid therapy for chronic pain...Paul Coelho, MD
The document discusses the challenges clinicians face when tapering patients off long-term opioid therapy for chronic pain. It explains that opioid dependence can cause worsening pain, psychiatric symptoms, and functioning during tapering due to neuroplastic changes. While tapering seems logical to address risks of high-dose opioids, it may paradoxically make a patient's issues worse due to protracted abstinence syndrome. The document provides guidance for managing these complex patients focused on both pain and opioid dependence.
This randomized clinical trial tested the effectiveness of stellate ganglion block (SGB) treatment compared to a sham procedure for reducing posttraumatic stress disorder (PTSD) symptoms over 8 weeks. 113 active-duty service members with PTSD symptoms were randomly assigned to receive either 2 SGB treatments 2 weeks apart or a sham procedure. The primary outcome was change in PTSD symptom severity scores measured by the CAPS-5 scale from baseline to 8 weeks. Participants receiving SGB had a greater reduction in symptoms scores compared to the sham group, with adjusted mean decreases of 12.6 vs 6.1 points respectively, indicating SGB treatment may help reduce PTSD symptoms.
This study surveyed behavioral health clinicians with experience using stellate ganglion block (SGB) as an adjunct treatment for trauma-related disorders like PTSD. Of the 23 respondents, 95% would recommend SGB to colleagues. Respondents rated SGB as at least as useful as the highest rated standard PTSD interventions. SGB was seen as most helpful for reducing arousal/reactivity symptoms. The majority would refer patients for SGB at any stage of therapy, including before starting other treatments.
Principles for more cautious and selective opioid prescribing for chronic non...Group Health Cooperative
Presentation was originally done at Group Health Cooperative’s National Summit on Opioid Safety: http://www.ghinnovates.org/?p=3502
Presentation by: Jane C. Ballantyne, MD FRCA, with the Department of Anesthesiology and Pain Medicine at UW Medicine.
This document summarizes three studies on the risks and efficacy of opioids for chronic non-cancer pain (CNP). The first study finds that while opioids were associated with small improvements in pain and physical functioning compared to placebo, they also increased the risk of vomiting. Comparisons to other medications found similar benefits to pain and functioning. The second study finds no difference in pain-related function between opioid and non-opioid groups over 12 months, and higher rates of adverse effects and pain intensity in the opioid group. The third study finds limited effectiveness of opioids for CNP, as opioid users did not report improvements in outcomes after 2 years. Regarding risks, higher opioid doses are associated with increased overdose risk across several patient groups in
The document summarizes a national summit on opioid safety convened to develop consensus on safer opioid prescribing practices for chronic non-cancer pain. The summit goals were to: 1) develop consensus principles for more selective, cautious opioid use; 2) share approaches to mitigate risks; 3) share how to change practice and implement guidelines. It provided background on the opioid epidemic and research showing risks increasing with higher doses and limited evidence of long-term benefits. Draft principles for safer opioid prescribing included starting with non-opioid treatments, carefully evaluating risks, limiting dose escalation, and tapering patients off opioids when risks outweigh benefits.
- This interim analysis of an ongoing observational study found that topical analgesics may reduce pain severity and interference scores and decrease primary pain complaints and oral pain medication use for patients with neuropathic or musculoskeletal pain.
- Overall patient satisfaction with topical analgesics was high and they were found to be safe and well-tolerated.
- The results were consistent with a previous interim analysis and warrant continuation of the larger OPERA study, though more analysis is still needed.
The conundrum of opioid tapering in long term opioid therapy for chronic pain...Paul Coelho, MD
The document discusses the challenges clinicians face when tapering patients off long-term opioid therapy for chronic pain. It explains that opioid dependence can cause worsening pain, psychiatric symptoms, and functioning during tapering due to neuroplastic changes. While tapering seems logical to address risks of high-dose opioids, it may paradoxically make a patient's issues worse due to protracted abstinence syndrome. The document provides guidance for managing these complex patients focused on both pain and opioid dependence.
This randomized clinical trial tested the effectiveness of stellate ganglion block (SGB) treatment compared to a sham procedure for reducing posttraumatic stress disorder (PTSD) symptoms over 8 weeks. 113 active-duty service members with PTSD symptoms were randomly assigned to receive either 2 SGB treatments 2 weeks apart or a sham procedure. The primary outcome was change in PTSD symptom severity scores measured by the CAPS-5 scale from baseline to 8 weeks. Participants receiving SGB had a greater reduction in symptoms scores compared to the sham group, with adjusted mean decreases of 12.6 vs 6.1 points respectively, indicating SGB treatment may help reduce PTSD symptoms.
This study surveyed behavioral health clinicians with experience using stellate ganglion block (SGB) as an adjunct treatment for trauma-related disorders like PTSD. Of the 23 respondents, 95% would recommend SGB to colleagues. Respondents rated SGB as at least as useful as the highest rated standard PTSD interventions. SGB was seen as most helpful for reducing arousal/reactivity symptoms. The majority would refer patients for SGB at any stage of therapy, including before starting other treatments.
Principles for more cautious and selective opioid prescribing for chronic non...Group Health Cooperative
Presentation was originally done at Group Health Cooperative’s National Summit on Opioid Safety: http://www.ghinnovates.org/?p=3502
Presentation by: Jane C. Ballantyne, MD FRCA, with the Department of Anesthesiology and Pain Medicine at UW Medicine.
This document summarizes three studies on the risks and efficacy of opioids for chronic non-cancer pain (CNP). The first study finds that while opioids were associated with small improvements in pain and physical functioning compared to placebo, they also increased the risk of vomiting. Comparisons to other medications found similar benefits to pain and functioning. The second study finds no difference in pain-related function between opioid and non-opioid groups over 12 months, and higher rates of adverse effects and pain intensity in the opioid group. The third study finds limited effectiveness of opioids for CNP, as opioid users did not report improvements in outcomes after 2 years. Regarding risks, higher opioid doses are associated with increased overdose risk across several patient groups in
The document summarizes a national summit on opioid safety convened to develop consensus on safer opioid prescribing practices for chronic non-cancer pain. The summit goals were to: 1) develop consensus principles for more selective, cautious opioid use; 2) share approaches to mitigate risks; 3) share how to change practice and implement guidelines. It provided background on the opioid epidemic and research showing risks increasing with higher doses and limited evidence of long-term benefits. Draft principles for safer opioid prescribing included starting with non-opioid treatments, carefully evaluating risks, limiting dose escalation, and tapering patients off opioids when risks outweigh benefits.
This study evaluated the risk of opioid abuse in 202 chronic pain patients by addiction psychiatry fellows in an academic pain center. Most consultations were requested by less experienced pain practitioners and focused on assessing risk of continued opioid therapy. Abnormal toxicology results were found in 63% of patients referred, and only 2% were ultimately recommended for continued opioid therapy. The addiction psychiatry fellows found this rotation valuable for their training in evaluating prescription opioid risk. The study suggests supervised addiction psychiatry fellows can effectively conduct opioid risk assessments.
The document provides revised recommendations for the management of fibromyalgia based on a review of evidence from systematic reviews and meta-analyses published since the original 2005 guidelines. Key findings include:
- Exercise was the only intervention with a "strong for" recommendation based on meta-analyses showing benefits for pain, fatigue, sleep and functioning.
- A graduated four-stage approach is proposed, beginning with patient education and non-pharmacological therapies. Pharmacological therapies (amitriptyline, pregabalin, cyclobenzaprine, duloxetine, milnacipran) received "weak for" recommendations for severe pain or sleep issues.
- Growth hormone, sodium oxybate, NSAIDs, S
The document provides revised recommendations for the management of fibromyalgia based on a review of evidence from systematic reviews and meta-analyses published since the original 2005 guidelines. Key findings include:
- Exercise is the only therapy strongly recommended based on meta-analyses showing benefit for pain, sleep, and functioning.
- A graduated four-stage approach is proposed, beginning with patient education and non-pharmacological therapies.
- If non-response, further therapies such as psychological therapies, pharmacotherapy, or rehabilitation may be tailored to the individual. However, meta-analyses only found weak evidence for all potential pharmacological therapies.
- Most treatments show relatively modest effects. Future research priorities are identifying who benefits from specific interventions,
This document provides information about an upcoming conference on pain therapeutics taking place from May 22-24, 2017 in London. It summarizes the conference agenda, speakers, and topics to be discussed over the two day event and half day workshop. Key highlights include:
- The conference will focus on strategies for pain management, evaluating translation between pre-clinical and clinical studies, assessing animal models for studying pain pathways, and examining new case studies from pharmaceutical companies.
- Speakers will address topics like CGRP receptor antagonists for migraine, developing novel pain treatments, using veterinary trials to inform human research, biomarkers for pain pathways, and new therapeutic approaches for pain including Kappa opioid receptor agonists.
-
This document provides information on the approach to managing neuropathic pain in patients with diabetes. It begins by defining neuropathic pain and distinguishing it from nociceptive pain. It describes the complex nature of neuropathic pain, which can involve damage to different nerve fiber types and various excitatory and inhibitory neurotransmitters. More importantly, the pathogenesis of nerve damage is often multifactorial and can include metabolic disturbances, oxidative stress, vascular insufficiencies, and autoimmune processes. The approach to patients involves understanding the underlying cause of their pain in order to use targeted therapies. Simply prescribing general pain medications is insufficient and does not address the disease process causing the pain. The case study illustrates the need for a holistic approach employing empathy, understanding and
1) The study evaluated the prevalence of neuropathic pain in patients undergoing carpal tunnel release surgery and the outcomes of surgery on neuropathic pain.
2) They found that 72% of patients reported neuropathic pain pre-operatively and 36% still reported it post-operatively.
3) Patients with pre-operative neuropathic pain were more likely to have surgery on the left side and those receiving pre-operative corticosteroid injections had worse functional outcomes post-surgery. The study highlights the need for multi-disciplinary management of neuropathic pain after carpal tunnel release surgery.
WEX Pharmaceuticals is developing tetrodotoxin (TTX), a new class of non-opioid analgesic, for the treatment of moderate to severe cancer pain and chemotherapy-induced neuropathic pain. TTX works by blocking voltage-gated sodium channels associated with pain and has shown efficacy in Phase 2 trials with no opioid-like side effects. WEX is currently conducting a Phase 3 trial in cancer pain and plans to initiate a Phase 2 trial for chemotherapy-induced neuropathic pain. Positive interim results are expected in 2010-2011 which could support the approval and commercialization of the first non-opioid option for managing severe chronic pain.
The document summarizes a study that aimed to map the underlying structure of the at-risk mental state (ARMS) by defining dimensions of subclinical psychopathology in ARMS subjects. 316 participants meeting criteria for ARMS were assessed using the CAARMS interview and other measures. Principal component analysis of the CAARMS items yielded five interpretable components ("Depression", "Disorganization", "Bodily-impairment", "Manic", and "Schizo-affective"). The "Depression" component was most strongly related to worse functioning and increased depressive symptoms. The identified components could provide a step towards a dimensional approach to assessing ARMS.
Nicholas Jewell MedicReS World Congress 2011MedicReS
Good Biostatistical Report Practices
Being Honest in Data Analysis
Nicholas P. Jewell
Departments of Statistics &
School of Public Health (Biostatistics)
University of California, Berkeley
March 26, 2011
The document discusses PTSD and emergence delirium in veterans undergoing surgery, defining the conditions, reviewing evidence on risk factors and treatments, and proposing strategies for preoperative evaluation, intraoperative care, and postoperative management to prevent emergence delirium in high-risk patients and improve outcomes. It also examines the pathophysiology of how general anesthesia and PTSD may interact to increase risks of delirium and outlines areas for further research and dissemination of guidelines.
The document summarizes research on the role of nurses in activating rapid response teams (RRTs). It finds that nurses who use an analytical decision-making model activate RRTs more frequently and achieve better patient outcomes than those using intuitive or mixed models. Analytical decision-making involves collecting data, forming hypotheses, further data collection, analysis, and decision-making. The study emphasizes the importance of nurses' ability to recognize patient decline and respond effectively through frequent monitoring and timely RRT activation.
This document discusses delirium in the ICU, including:
1) Delirium is a common syndrome in ICU patients characterized by inattention and cognitive dysfunction. It is associated with increased mortality, length of stay, and long-term cognitive impairment.
2) Implementing an ABCDE bundle including awakening trials, breathing coordination, delirium monitoring/management, and early mobility can reduce delirium incidence and improve outcomes.
3) Non-pharmacological interventions like reorientation, mobility, and minimizing sedative exposure are important for preventing and treating delirium.
This document discusses issues in assessing and treating patients with co-occurring opiate dependence and chronic pain. It notes that while opiate treatment is commonly used for chronic pain, it can lead to physical dependence, tolerance, and potentially addiction. Assessing for problematic opioid use or addiction involves looking for behaviors like frequent dose increases, non-medical use, doctor shopping, or illicit drug use. Factors like a history of substance abuse or mental health conditions may increase risk. Proper evaluation and treatment should address both the pain condition and risk for opioid misuse or addiction.
This article discusses the need to increase openness and discussion about death and dying in society. A lack of discussion can negatively impact end-of-life care and leave the bereaved feeling unprepared. While surveys show public support for assisted dying, most people prefer to die at home if possible and welcome advance care planning discussions with healthcare providers. Attitudes vary depending on demographics, and increasing awareness of palliative care options through public education initiatives could improve end-of-life experiences.
cannabidiol therapy in the treatment of chronic painAllison Piela
Patients who receive cannabidiol therapy may report less pain than those who do not according to a proposed research study. The study would involve 800 chronic pain patients randomized to receive one of three treatments - a combination THC/CBD spray, a CBD-only spray, or a placebo spray. Pain levels would be self-reported weekly on a numeric scale. The study aims to establish effective dosages of cannabidiol for pain relief and provide data to health professionals and policymakers. Anticipated challenges include ensuring proper patient adherence to their assigned medication protocol.
The Efficacy and Safety of Tocilizumab in the Treatment of Rheumatoid Arthrit...RemedyPublications
Tocilizumab (TCZ) has variously been approved in combination with Methotrexate for the
treatment of Rheumatoid Arthritis (RA) in adults. The objectives of this Non-Interventional Study
(NIS) were to assess the efficacy and safety of TCZ in routine clinical use.
Clinical response to TCZ was evaluated by collecting Disease Activity Score 28 (DAS28) and other
efficacy parameters. The number and type of Adverse Events (AEs) and concomitant medication
were documented. The median treatment duration was 52 weeks.
The efficacy and safety analyses included 590 patients, 97.8% of whom had been pretreated with
disease-modifying anti-rheumatic drugs. DAS28 scores were available for 484 patients, of whom
67.98% experienced disease remission and 83.06% low disease activity at any time during treatment.
AEs were reported for 21.02% of the patients, with 10% serious events.
The results confirm that TCZ is efficacious and well tolerated in routine use for the treatment of RA.
As the results of this NIS are in line with existing data, a reevaluation of the risk-benefit balance of
TCZ for the treatment of RA does not seem necessary.
This document summarizes a presentation about a study conducted by MAPS on the long-term efficacy of ibogaine-assisted treatment for opioid addiction. The study aimed to determine if ibogaine treatment could facilitate long-term recovery by measuring periods of abstinence, reductions in opioid use, and improvements in quality of life. Preliminary results found that about 1/3 of participants relapsed within months, but 20% made it over 6 months and 4 made it over a year, suggesting ibogaine can interrupt addiction but is not a cure on its own
Để xem full tài liệu Xin vui long liên hệ page để được hỗ trợ
: https://www.facebook.com/thuvienluanvan01
HOẶC
https://www.facebook.com/garmentspace/
https://www.facebook.com/thuvienluanvan01
https://www.facebook.com/thuvienluanvan01
tai lieu tong hop, thu vien luan van, luan van tong hop, do an chuyen nganh
- 49% of chronic pain patients taking opioids reported severe pain (≥7/10).
- Patients reporting higher pain were more likely to have characteristics associated with centralized pain processing, including higher fibromyalgia survey scores, more neuropathic pain symptoms, and higher depression levels.
- While only 3.2% were diagnosed with fibromyalgia by their doctor, 40.8% met criteria for fibromyalgia based on a validated survey questionnaire. This suggests centralized pain characteristics are underrecognized.
An overview of drug regulatory system in South AfricaSriramNagarajan17
This study compared the use of opioid and non-opioid analgesics for cancer pain treatment in 100 patients over 8 months. The study found that opioids were the most commonly prescribed drug for cancer pain (89% of patients), followed by non-opioids (11% of patients). The minor side effects of opioids occurred in 85% of patients, while major side effects occurred in 15% of patients. Therefore, the study concluded that opioids were effective for treating severe cancer pain with relatively few adverse effects.
Study of Analgesic usage In a Tertiary Care.pptxHariHaran726642
This document outlines a study to assess analgesic usage patterns at the outpatient departments of a tertiary hospital in India. The study will involve collecting data on analgesics prescribed to patients aged 18-60 across several outpatient departments. The objectives are to document conditions analgesics are prescribed for, determine any cases requiring caution, and assess prescribing practices to promote rational analgesic use. Data on analgesic class, dosage, frequency, number prescribed, and generic name will be gathered from prescriptions and analyzed statistically. The goal is to identify commonly prescribed analgesics and provide information to optimize pain management and treatment.
This study evaluated the risk of opioid abuse in 202 chronic pain patients by addiction psychiatry fellows in an academic pain center. Most consultations were requested by less experienced pain practitioners and focused on assessing risk of continued opioid therapy. Abnormal toxicology results were found in 63% of patients referred, and only 2% were ultimately recommended for continued opioid therapy. The addiction psychiatry fellows found this rotation valuable for their training in evaluating prescription opioid risk. The study suggests supervised addiction psychiatry fellows can effectively conduct opioid risk assessments.
The document provides revised recommendations for the management of fibromyalgia based on a review of evidence from systematic reviews and meta-analyses published since the original 2005 guidelines. Key findings include:
- Exercise was the only intervention with a "strong for" recommendation based on meta-analyses showing benefits for pain, fatigue, sleep and functioning.
- A graduated four-stage approach is proposed, beginning with patient education and non-pharmacological therapies. Pharmacological therapies (amitriptyline, pregabalin, cyclobenzaprine, duloxetine, milnacipran) received "weak for" recommendations for severe pain or sleep issues.
- Growth hormone, sodium oxybate, NSAIDs, S
The document provides revised recommendations for the management of fibromyalgia based on a review of evidence from systematic reviews and meta-analyses published since the original 2005 guidelines. Key findings include:
- Exercise is the only therapy strongly recommended based on meta-analyses showing benefit for pain, sleep, and functioning.
- A graduated four-stage approach is proposed, beginning with patient education and non-pharmacological therapies.
- If non-response, further therapies such as psychological therapies, pharmacotherapy, or rehabilitation may be tailored to the individual. However, meta-analyses only found weak evidence for all potential pharmacological therapies.
- Most treatments show relatively modest effects. Future research priorities are identifying who benefits from specific interventions,
This document provides information about an upcoming conference on pain therapeutics taking place from May 22-24, 2017 in London. It summarizes the conference agenda, speakers, and topics to be discussed over the two day event and half day workshop. Key highlights include:
- The conference will focus on strategies for pain management, evaluating translation between pre-clinical and clinical studies, assessing animal models for studying pain pathways, and examining new case studies from pharmaceutical companies.
- Speakers will address topics like CGRP receptor antagonists for migraine, developing novel pain treatments, using veterinary trials to inform human research, biomarkers for pain pathways, and new therapeutic approaches for pain including Kappa opioid receptor agonists.
-
This document provides information on the approach to managing neuropathic pain in patients with diabetes. It begins by defining neuropathic pain and distinguishing it from nociceptive pain. It describes the complex nature of neuropathic pain, which can involve damage to different nerve fiber types and various excitatory and inhibitory neurotransmitters. More importantly, the pathogenesis of nerve damage is often multifactorial and can include metabolic disturbances, oxidative stress, vascular insufficiencies, and autoimmune processes. The approach to patients involves understanding the underlying cause of their pain in order to use targeted therapies. Simply prescribing general pain medications is insufficient and does not address the disease process causing the pain. The case study illustrates the need for a holistic approach employing empathy, understanding and
1) The study evaluated the prevalence of neuropathic pain in patients undergoing carpal tunnel release surgery and the outcomes of surgery on neuropathic pain.
2) They found that 72% of patients reported neuropathic pain pre-operatively and 36% still reported it post-operatively.
3) Patients with pre-operative neuropathic pain were more likely to have surgery on the left side and those receiving pre-operative corticosteroid injections had worse functional outcomes post-surgery. The study highlights the need for multi-disciplinary management of neuropathic pain after carpal tunnel release surgery.
WEX Pharmaceuticals is developing tetrodotoxin (TTX), a new class of non-opioid analgesic, for the treatment of moderate to severe cancer pain and chemotherapy-induced neuropathic pain. TTX works by blocking voltage-gated sodium channels associated with pain and has shown efficacy in Phase 2 trials with no opioid-like side effects. WEX is currently conducting a Phase 3 trial in cancer pain and plans to initiate a Phase 2 trial for chemotherapy-induced neuropathic pain. Positive interim results are expected in 2010-2011 which could support the approval and commercialization of the first non-opioid option for managing severe chronic pain.
The document summarizes a study that aimed to map the underlying structure of the at-risk mental state (ARMS) by defining dimensions of subclinical psychopathology in ARMS subjects. 316 participants meeting criteria for ARMS were assessed using the CAARMS interview and other measures. Principal component analysis of the CAARMS items yielded five interpretable components ("Depression", "Disorganization", "Bodily-impairment", "Manic", and "Schizo-affective"). The "Depression" component was most strongly related to worse functioning and increased depressive symptoms. The identified components could provide a step towards a dimensional approach to assessing ARMS.
Nicholas Jewell MedicReS World Congress 2011MedicReS
Good Biostatistical Report Practices
Being Honest in Data Analysis
Nicholas P. Jewell
Departments of Statistics &
School of Public Health (Biostatistics)
University of California, Berkeley
March 26, 2011
The document discusses PTSD and emergence delirium in veterans undergoing surgery, defining the conditions, reviewing evidence on risk factors and treatments, and proposing strategies for preoperative evaluation, intraoperative care, and postoperative management to prevent emergence delirium in high-risk patients and improve outcomes. It also examines the pathophysiology of how general anesthesia and PTSD may interact to increase risks of delirium and outlines areas for further research and dissemination of guidelines.
The document summarizes research on the role of nurses in activating rapid response teams (RRTs). It finds that nurses who use an analytical decision-making model activate RRTs more frequently and achieve better patient outcomes than those using intuitive or mixed models. Analytical decision-making involves collecting data, forming hypotheses, further data collection, analysis, and decision-making. The study emphasizes the importance of nurses' ability to recognize patient decline and respond effectively through frequent monitoring and timely RRT activation.
This document discusses delirium in the ICU, including:
1) Delirium is a common syndrome in ICU patients characterized by inattention and cognitive dysfunction. It is associated with increased mortality, length of stay, and long-term cognitive impairment.
2) Implementing an ABCDE bundle including awakening trials, breathing coordination, delirium monitoring/management, and early mobility can reduce delirium incidence and improve outcomes.
3) Non-pharmacological interventions like reorientation, mobility, and minimizing sedative exposure are important for preventing and treating delirium.
This document discusses issues in assessing and treating patients with co-occurring opiate dependence and chronic pain. It notes that while opiate treatment is commonly used for chronic pain, it can lead to physical dependence, tolerance, and potentially addiction. Assessing for problematic opioid use or addiction involves looking for behaviors like frequent dose increases, non-medical use, doctor shopping, or illicit drug use. Factors like a history of substance abuse or mental health conditions may increase risk. Proper evaluation and treatment should address both the pain condition and risk for opioid misuse or addiction.
This article discusses the need to increase openness and discussion about death and dying in society. A lack of discussion can negatively impact end-of-life care and leave the bereaved feeling unprepared. While surveys show public support for assisted dying, most people prefer to die at home if possible and welcome advance care planning discussions with healthcare providers. Attitudes vary depending on demographics, and increasing awareness of palliative care options through public education initiatives could improve end-of-life experiences.
cannabidiol therapy in the treatment of chronic painAllison Piela
Patients who receive cannabidiol therapy may report less pain than those who do not according to a proposed research study. The study would involve 800 chronic pain patients randomized to receive one of three treatments - a combination THC/CBD spray, a CBD-only spray, or a placebo spray. Pain levels would be self-reported weekly on a numeric scale. The study aims to establish effective dosages of cannabidiol for pain relief and provide data to health professionals and policymakers. Anticipated challenges include ensuring proper patient adherence to their assigned medication protocol.
The Efficacy and Safety of Tocilizumab in the Treatment of Rheumatoid Arthrit...RemedyPublications
Tocilizumab (TCZ) has variously been approved in combination with Methotrexate for the
treatment of Rheumatoid Arthritis (RA) in adults. The objectives of this Non-Interventional Study
(NIS) were to assess the efficacy and safety of TCZ in routine clinical use.
Clinical response to TCZ was evaluated by collecting Disease Activity Score 28 (DAS28) and other
efficacy parameters. The number and type of Adverse Events (AEs) and concomitant medication
were documented. The median treatment duration was 52 weeks.
The efficacy and safety analyses included 590 patients, 97.8% of whom had been pretreated with
disease-modifying anti-rheumatic drugs. DAS28 scores were available for 484 patients, of whom
67.98% experienced disease remission and 83.06% low disease activity at any time during treatment.
AEs were reported for 21.02% of the patients, with 10% serious events.
The results confirm that TCZ is efficacious and well tolerated in routine use for the treatment of RA.
As the results of this NIS are in line with existing data, a reevaluation of the risk-benefit balance of
TCZ for the treatment of RA does not seem necessary.
This document summarizes a presentation about a study conducted by MAPS on the long-term efficacy of ibogaine-assisted treatment for opioid addiction. The study aimed to determine if ibogaine treatment could facilitate long-term recovery by measuring periods of abstinence, reductions in opioid use, and improvements in quality of life. Preliminary results found that about 1/3 of participants relapsed within months, but 20% made it over 6 months and 4 made it over a year, suggesting ibogaine can interrupt addiction but is not a cure on its own
Để xem full tài liệu Xin vui long liên hệ page để được hỗ trợ
: https://www.facebook.com/thuvienluanvan01
HOẶC
https://www.facebook.com/garmentspace/
https://www.facebook.com/thuvienluanvan01
https://www.facebook.com/thuvienluanvan01
tai lieu tong hop, thu vien luan van, luan van tong hop, do an chuyen nganh
- 49% of chronic pain patients taking opioids reported severe pain (≥7/10).
- Patients reporting higher pain were more likely to have characteristics associated with centralized pain processing, including higher fibromyalgia survey scores, more neuropathic pain symptoms, and higher depression levels.
- While only 3.2% were diagnosed with fibromyalgia by their doctor, 40.8% met criteria for fibromyalgia based on a validated survey questionnaire. This suggests centralized pain characteristics are underrecognized.
An overview of drug regulatory system in South AfricaSriramNagarajan17
This study compared the use of opioid and non-opioid analgesics for cancer pain treatment in 100 patients over 8 months. The study found that opioids were the most commonly prescribed drug for cancer pain (89% of patients), followed by non-opioids (11% of patients). The minor side effects of opioids occurred in 85% of patients, while major side effects occurred in 15% of patients. Therefore, the study concluded that opioids were effective for treating severe cancer pain with relatively few adverse effects.
Study of Analgesic usage In a Tertiary Care.pptxHariHaran726642
This document outlines a study to assess analgesic usage patterns at the outpatient departments of a tertiary hospital in India. The study will involve collecting data on analgesics prescribed to patients aged 18-60 across several outpatient departments. The objectives are to document conditions analgesics are prescribed for, determine any cases requiring caution, and assess prescribing practices to promote rational analgesic use. Data on analgesic class, dosage, frequency, number prescribed, and generic name will be gathered from prescriptions and analyzed statistically. The goal is to identify commonly prescribed analgesics and provide information to optimize pain management and treatment.
This study compared chronic pain patients whose symptoms were considered medically unexplained (cases) to those whose symptoms had clear medical explanations (controls). The key findings were:
1. Medically unexplained symptoms were associated with higher rates of psychiatric morbidity, including a 3.4 times higher odds of any psychiatric diagnosis.
2. Cases reported more potential iatrogenic factors like over-investigation and over-treatment from healthcare providers compared to controls.
3. There were no significant differences between cases and controls in rates of medication abuse or dependence.
An Internet questionnaire to identify Drug seeking behavior in a patient in t...Nelson Hendler
Drug seeking behavior in patients with little or no real pain, has led to the opioid crisis. Until now, there was no reliable method for detecting drug seeking behavior. The Pain Validity Test from www.MarylandClinicalDiagnostics.com can predict with 95% accuracy who will have medical test abnormalities, i.e. who has a valid complaint of pain, and predicts with 85%-100% accuracy who will not have any medical test abnormalities, i.e. who is faking and drug seeking. The Pain Validity Test has been admitted as evidence in over 30 legal cases in 8 states.
Pain Validity Test to detect drug seeking behaviorNelson Hendler
The Pain Validity Test predicts which patient will have medical test abnormalities with 95% accuracy, thereby validating their complaint of pain. The Pain Validity Test also predicts with 85%-100% accuracy who will not have medical test abnormalities, thereby detecting drug seeking behavior, faking and malingering.
Pain Validity Test identifies drug seeking behavior. Stop opioid abuse. Prote...Nelson Hendler
Physician prescribing practices are under constant scrutiny. An Internet questionnaire will predict if a patient will have a medical test abnormality with 95% accuracy, and 100% if the patient will not. This Pain Validity Test can be used to detect drug seeking behavior in patients, at a far high level of accuracy than tests currently in use (34.4%-48.2% accuracy).. The Pain Validity test has been admitted as evidence in 30 cases in 9 states.
Predicting Medical Test Results and Intra-Operative Findings in Chronic Pain ...Nelson Hendler
The Pain Validity Test can predict which patient will have abnormal medical test results with 95% accuracy, and surgical abnormalities with 94% accuracy. This on-line questionnaire takes only 5 minutes of staff time to administer, and takes only 15 minutes of patient time.Results are available immediately. This test can be used to document "medical necessity" for insurance pre-authorization for testing and surgery.
How to prevent acute pain developing into chronic pain,
How to treat pain without resorting to opioids
How genetics, diet, and lifestyle all influence a person’s pain and whether it will become chronic.
How patterns of gene expression predict pain
How Big data can tell us about why people transition from acute to chronic pain
iCAAD London 2019 - Mel Pohl - CHRONIC PAIN AND ADDICTION: HOW WE MISSED THE...iCAADEvents
The document discusses chronic pain and addiction. It notes that while all pain is real, emotions drive the experience of chronic pain. Opioids are often ineffective in treating chronic pain and can actually make pain worse. The goals of pain management should be to maintain or improve function rather than just reducing pain. Non-medication treatments like exercise, massage, and mindfulness can be effective alternatives or supplements to medication for chronic pain.
Scrambler Therapy May Relieve Chronic Neuropathic Pain More Effectively Than Guideline-Based Drug Management: Results of a Pilot, Randomized, Controlled Trial
1) This randomized clinical trial compared opioid vs nonopioid medication therapy over 12 months for patients with chronic back, hip, or knee pain.
2) It found no significant difference in pain-related function between the two groups, but pain intensity was significantly better in the nonopioid group. Adverse effects were significantly more common in the opioid group.
3) The study concludes that opioid therapy was not superior to nonopioid medications for improving pain-related function over 12 months, and the results do not support initiating opioids for moderate to severe chronic musculoskeletal pain.
Pressures sensitivity & phenotypic changes in patients with suspected oih bei...Paul Coelho, MD
1) The study assessed changes in pain phenotype and pressure sensitivity in 20 patients with suspected opioid-induced hyperalgesia (OIH) after transitioning from full mu opioid agonists to buprenorphine therapy.
2) Patients on higher opioid doses (≥100 mg oral morphine equivalents) had significant improvements in measures of pain, mood, and function 1 week after starting buprenorphine, with eventual return to baseline.
3) Patients on higher opioid doses also showed a non-significant trend of decreased pressure pain sensitivity 1 week after starting buprenorphine, eventually returning to baseline.
Current methods of fraud detection used by insurance companies are not cost effective. This presentation describes the inaccuracy of the MMPI, and presents a new test, which can predict who will had medical test abnormalites with 95% accuracy, and who wil not have medical test abnormalities with 85% accuracy (the fakers). Available in English and Spanish at www.MarylandClinicalDiagnostics.com
Current methods of fraud detection used by insurance companies are not cost effective. This presentation describes the inaccuracy of the MMPI, and presents a new test, which can predict who will had medical test abnormalites with 95% accuracy, and who wil not have medical test abnormalities with 85% accuracy (the fakers). Available in English and Spanish at www.MarylandClinicalDiagnostics.com
INFLUENCE OF DEMOGRAPHIC FACTORS ON PAIN KILLER USAGE AND ADDICTION SYMPTOMSJing Zang
Pain killers have been a necessity for humans since their skin has been laden with pain receptors to signal them against any invasion or unusual going on in the body.This pain when exceeds the limits of tolerance has to be alleviated to reduce suffering. Since ancient times numerous natural substances like herbs and oils have been used to relieve pain, but in modern era more refined ways to relieve pain have been discovered that exactly target the precise pain. This research identifies the factors that govern painkiller usage and addiction and the people who, in majority fall prey to pleasures of pain killers. The research was carried out through a questionnaire and results were statistically analyzed by fishers exact test. Males, employed people, non medics and graduates are most attracted to pain killers and are susceptible to long term addiction. The reasons for these people falling prey to pain killers are work load, mental stress and physiological responses to the drug. These factors can be managed through proper intervention by health professionals. The role of friends and family too here cannot be ignored.
This document discusses pain management in cancer patients. It covers the pathophysiology of pain, assessment strategies, drug and non-drug treatment options, managing special populations, patient education, and Joint Commission standards. The key aspects are conducting a comprehensive initial pain assessment, developing an individualized treatment plan using the WHO analgesic ladder as a guide, treating breakthrough pain, managing side effects, and employing multimodal therapies including pharmacological and nonpharmacological options.
Austin Pain & Relief is an open access, peer reviewed, scholarly journal dedicated to publish articles covering all areas of Pain & Relief.
The journal aims to promote research communications and provide a forum for doctors, researchers, physicians and healthcare professionals to find most recent advances in all areas of Pain & Relief. Austin Pain & Relief accepts original research articles, reviews, mini reviews, case reports and rapid communication covering all aspects of pain and relief.
Austin Pain & Relief strongly supports the scientific up gradation and fortification in related scientific research community by enhancing access to peer reviewed scientific literary works. Austin Publishing Group also brings universally peer reviewed journals under one roof thereby promoting knowledge sharing, mutual promotion of multidisciplinary science.
This document discusses pain, its types, effects, assessment, and management. It defines pain and outlines types including acute, chronic, neuropathic, and postoperative pain. It describes physiological and behavioral responses to pain and factors influencing pain. Methods of pain assessment including scales, questionnaires, and initial evaluation are provided. The importance of pain management and various pharmacological and non-pharmacological approaches are summarized.
This study compared patient pain scores to those assessed by emergency healthcare providers (doctors and triage nurses) in the emergency department of a large Malaysian hospital. The mean patient pain score on arrival was 6.8 out of 10, significantly higher than scores assessed by doctors (5.6) and triage nurses (4.3). Significant differences were found for 5 specific conditions: soft tissue injury, headache, abdominal pain, fracture, and abscess/cellulitis. Upon discharge or admission, nearly half of patients still reported moderate pain, suggesting undertreatment of pain in the emergency department. Accurately assessing patient-reported pain scores is important for effective pain management in emergency medicine.
Similar to Medication for pain without opiods (20)
Third Party Reporting of Patient Improvement.docxNelson Hendler
Reproting of outcome studies is often subjective. This collection of real leterrs, emails, and Facebook posting provides third party documentation and validation of the efficacy of treatment, without the subjective bias of the party doing the treatment.
Johns Hopkins Hospital doctors report that 40%-80% of chronic pain patient are misdiagnosed, and that MRIs and CTs miss pathology 56%-78% of the time, Therefore, during extensive chart reviews of current medical data will produce a classic case of GIGO-garbage in giving garbage out. The need for accurate diagnoses and testing is critical for AI to work.
Top_Down_or_The_Bottom_Up to Save Money.pdfNelson Hendler
The article describes the need for a more "granular:" assessment of workers' compensation claims, rather than the typical approach of insurance carriers which average large numbers, which causes the loss of valuable data.
The former head of HR for Burger King, British Petroleum, and Walmart, and former Assist. Prof. of Neurosurgery from Johns Hopkins Hospital describe methods to save 54% on workers' compensation using on-line "expert system" questionnaire from Johns Hopkins Hospital doctors
40%-80% of auto accident claimants have overlooked diagnoses. The most commonly overlooked are thoracic outlet syndrome, cervical disc damage mistakenly called sprain or whiplash, post-concussion syndrome, slipping rib syndrome, Tietze syndrome and Tempro-mandibular joint syndrome. This article tells readers the clinical sign and symptoms of each and the correct medical tests to use, which are employed by doctors at Johns Hopkins Hospital. It also described an on-line questionnaire at www.DiagnoseThePains.com which gives diagnoses with a 96% correlation with diagnoses of Johns Hopkins Hospital doctors.
This paper shows how thermography can be used to disprove the misdiagnosis and over used diagnosis of "psychogenic pain." in a group of chronic pain patients.
This article outlines the differences between the anatomical and pharmacological differences between acute and chronic pain. This has significant implications for treatment, since they really are separate disorders.
This study compares the effect of benzodiazepines to narcotics on EEG, memory quotient, and WAIS testing. Valium, Librium, Dalmane and other benzodiazepines produced EEG and cognitive abnormalities in 70% of the patients, while only 30% of patients on narcotics had cognitive impairment.and EEG abnormalities.
Bi-polar patients who were having side-effects from lithium were given spironolactone to control mood swings. Five the 6 had good control for 1 year. The mechanism of membrane stabilization compared to lithium are discussed.
Emg vs. thermography to diagnose crps and radiculopthyNelson Hendler
This large clinical trial (803) patients compares the accuracy of thermography to EMG studies to see which one was a better diagnostic tool for each disorder and the degree of overlap between testing.
Valuable info for orthopedic and neurosurgeons specializing in spinal injuriesNelson Hendler
Reports from Johns Hopkins Hospital doctors document that 40%-80% of patients labeled as soft tissue injury, whiplash, sprain or strain are misdiagnosed. Use of an Internet expert system provides diagnoses with a 96% correlation with diagnoses of former Johns Hopkins Hospital doctors, resulting in a 192% increase in interventional testing, and a 50%-63% increase in surgery in previously misdiagnosed patients, 93% of whom report good to excellent improvement after surgery. .
Headache diagnostc paradigm from former Johns Hopkins Hospital staffNelson Hendler
The medical literature reports that 35%-70% of patients diagnosed with migraine headache do not have this order. The Internet based "expert system" developed by former Johns Hopkins Hospital staff, including the past president of the American Headache Society and American Academy of Pain Management provides an Internet based "expert system" which gives diagnoses with a 94% correlation with diagnosed of these doctors.
Missed Diagnoses association in Rear end collisions Nelson Hendler
There are a number of overlooked diagnoses which occur after a rear-end accident. This paper shows an attorney how to convert a misdiagnosed 'soft tissue injury case" into damaged cervical disc,TMJ, thoracic outlet syndrome,and post concussion syndrome using a diagnostic paradigm to get diagnoses with a 96% correlation with diagnoses of Johns Hopkins Hospital doctors. This improves patient care and increases recovery.
This list is all of the researchers who have published articles on the Pain Validity Test and Diagnostic Paradigm from www.MarylandClinicalDiagnostics.com
This document lists the authors of articles on the Pain Validity Test and the Diagnostic Paradigm and Treatment Algorithm. It includes current and former physicians, researchers, and administrators from Johns Hopkins University, Helsinki University, Sapienza University of Rome, and other medical institutions. Some authors held roles like department chairs, professors, and organization presidents.
This is a simplified instruction manual, with screen shots, which will teach staff members how to administer the on-line questionnaires from www.MarylandClinicalDiagnostics.com. It will take any staff member only 15 minutes to review the handbook. Once they have reviewed the handbook, it will take only 5 minutes of staff time to set up a patient to take the tests from www.MarylandClinicalDiagnostics.com
Three Dimensional CT Imaging in post-surgical "failed back" syndromeNelson Hendler
A team of physicians from Johns Hopkins Hospital document that a regular CT misses pathology 56% of the time compared to a 3D-CT. However, if the patient has had previous surgery, the CT misses pathology 76% of the time compared to a 3D-CT. The 3D-CT can be used to combat misdiagnosis of "psychogenic pain patients."
Discover the benefits of homeopathic medicine for irregular periods with our guide on 5 common remedies. Learn how these natural treatments can help regulate menstrual cycles and improve overall menstrual health.
Visit Us: https://drdeepikashomeopathy.com/service/irregular-periods-treatment/
PGx Analysis in VarSeq: A User’s PerspectiveGolden Helix
Since our release of the PGx capabilities in VarSeq, we’ve had a few months to gather some insights from various use cases. Some users approach PGx workflows by means of array genotyping or what seems to be a growing trend of adding the star allele calling to the existing NGS pipeline for whole genome data. Luckily, both approaches are supported with the VarSeq software platform. The genotyping method being used will also dictate what the scope of the tertiary analysis will be. For example, are your PGx reports a standalone pipeline or would your lab’s goal be to handle a dual-purpose workflow and report on PGx + Diagnostic findings.
The purpose of this webcast is to:
Discuss and demonstrate the approaches with array and NGS genotyping methods for star allele calling to prep for downstream analysis.
Following genotyping, explore alternative tertiary workflow concepts in VarSeq to handle PGx reporting.
Moreover, we will include insights users will need to consider when validating their PGx workflow for all possible star alleles and options you have for automating your PGx analysis for large number of samples. Please join us for a session dedicated to the application of star allele genotyping and subsequent PGx workflows in our VarSeq software.
Pictorial and detailed description of patellar instability with sign and symptoms and how to diagnose , what investigations you should go with and how to approach with treatment options . I have presented this slide in my 2nd year junior residency in orthopedics at LLRM medical college Meerut and got good reviews for it
After getting it read you will definitely understand the topic.
Giloy in Ayurveda - Classical Categorization and SynonymsPlanet Ayurveda
Giloy, also known as Guduchi or Amrita in classical Ayurvedic texts, is a revered herb renowned for its myriad health benefits. It is categorized as a Rasayana, meaning it has rejuvenating properties that enhance vitality and longevity. Giloy is celebrated for its ability to boost the immune system, detoxify the body, and promote overall wellness. Its anti-inflammatory, antipyretic, and antioxidant properties make it a staple in managing conditions like fever, diabetes, and stress. The versatility and efficacy of Giloy in supporting health naturally highlight its importance in Ayurveda. At Planet Ayurveda, we provide a comprehensive range of health services and 100% herbal supplements that harness the power of natural ingredients like Giloy. Our products are globally available and affordable, ensuring that everyone can benefit from the ancient wisdom of Ayurveda. If you or your loved ones are dealing with health issues, contact Planet Ayurveda at 01725214040 to book an online video consultation with our professional doctors. Let us help you achieve optimal health and wellness naturally.
These lecture slides, by Dr Sidra Arshad, offer a simplified look into the mechanisms involved in the regulation of respiration:
Learning objectives:
1. Describe the organisation of respiratory center
2. Describe the nervous control of inspiration and respiratory rhythm
3. Describe the functions of the dorsal and respiratory groups of neurons
4. Describe the influences of the Pneumotaxic and Apneustic centers
5. Explain the role of Hering-Breur inflation reflex in regulation of inspiration
6. Explain the role of central chemoreceptors in regulation of respiration
7. Explain the role of peripheral chemoreceptors in regulation of respiration
8. Explain the regulation of respiration during exercise
9. Integrate the respiratory regulatory mechanisms
10. Describe the Cheyne-Stokes breathing
Study Resources:
1. Chapter 42, Guyton and Hall Textbook of Medical Physiology, 14th edition
2. Chapter 36, Ganong’s Review of Medical Physiology, 26th edition
3. Chapter 13, Human Physiology by Lauralee Sherwood, 9th edition
Breast cancer: Post menopausal endocrine therapyDr. Sumit KUMAR
Breast cancer in postmenopausal women with hormone receptor-positive (HR+) status is a common and complex condition that necessitates a multifaceted approach to management. HR+ breast cancer means that the cancer cells grow in response to hormones such as estrogen and progesterone. This subtype is prevalent among postmenopausal women and typically exhibits a more indolent course compared to other forms of breast cancer, which allows for a variety of treatment options.
Diagnosis and Staging
The diagnosis of HR+ breast cancer begins with clinical evaluation, imaging, and biopsy. Imaging modalities such as mammography, ultrasound, and MRI help in assessing the extent of the disease. Histopathological examination and immunohistochemical staining of the biopsy sample confirm the diagnosis and hormone receptor status by identifying the presence of estrogen receptors (ER) and progesterone receptors (PR) on the tumor cells.
Staging involves determining the size of the tumor (T), the involvement of regional lymph nodes (N), and the presence of distant metastasis (M). The American Joint Committee on Cancer (AJCC) staging system is commonly used. Accurate staging is critical as it guides treatment decisions.
Treatment Options
Endocrine Therapy
Endocrine therapy is the cornerstone of treatment for HR+ breast cancer in postmenopausal women. The primary goal is to reduce the levels of estrogen or block its effects on cancer cells. Commonly used agents include:
Selective Estrogen Receptor Modulators (SERMs): Tamoxifen is a SERM that binds to estrogen receptors, blocking estrogen from stimulating breast cancer cells. It is effective but may have side effects such as increased risk of endometrial cancer and thromboembolic events.
Aromatase Inhibitors (AIs): These drugs, including anastrozole, letrozole, and exemestane, lower estrogen levels by inhibiting the aromatase enzyme, which converts androgens to estrogen in peripheral tissues. AIs are generally preferred in postmenopausal women due to their efficacy and safety profile compared to tamoxifen.
Selective Estrogen Receptor Downregulators (SERDs): Fulvestrant is a SERD that degrades estrogen receptors and is used in cases where resistance to other endocrine therapies develops.
Combination Therapies
Combining endocrine therapy with other treatments enhances efficacy. Examples include:
Endocrine Therapy with CDK4/6 Inhibitors: Palbociclib, ribociclib, and abemaciclib are CDK4/6 inhibitors that, when combined with endocrine therapy, significantly improve progression-free survival in advanced HR+ breast cancer.
Endocrine Therapy with mTOR Inhibitors: Everolimus, an mTOR inhibitor, can be added to endocrine therapy for patients who have developed resistance to aromatase inhibitors.
Chemotherapy
Chemotherapy is generally reserved for patients with high-risk features, such as large tumor size, high-grade histology, or extensive lymph node involvement. Regimens often include anthracyclines and taxanes.
Summer is a time for fun in the sun, but the heat and humidity can also wreak havoc on your skin. From itchy rashes to unwanted pigmentation, several skin conditions become more prevalent during these warmer months.
Travel vaccination in Manchester offers comprehensive immunization services for individuals planning international trips. Expert healthcare providers administer vaccines tailored to your destination, ensuring you stay protected against various diseases. Conveniently located clinics and flexible appointment options make it easy to get the necessary shots before your journey. Stay healthy and travel with confidence by getting vaccinated in Manchester. Visit us: www.nxhealthcare.co.uk
2. Page 2 of 5
Hendle N et al. Scimaze Anaesth Pain Management (2018) 1:101
Volume 1, Issue 1
Research ArticleOpen Access
The Diagnostic Paradigm and Treatment Algorithm can predict
intra-operative finding with 100% accuracy [25], The efficacy of
this approach is shown by outcome studies, as well as outcome
studies documenting consistent patient improvement after they
have properly diagnosed and correctly tested and treating by
following the recommendations of the Diagnostic Paradigm and
Treatment Algorithm [8,13,14]. Once a patient is accurately
diagnosed, and the source of the pain is identified, then selection
of medication can directed to treating the type of tissue damage
identified as the cause of the pain, instead of the mere symptomatic
“treatment of pain with narcotics.”
Acute Pain Anatomy and Pharmacology
Acute pain is a type of pain which is expected to resolve once
tissue damage is repaired. Anatomically, pharmacologically, and
emotionally, acute pain differs from chronic pain. This distinction
has critical clinical implications. Acute pain is due to damage to
tissue, and the message of pain is carried to the spinal cord, where
a synapse occurs, and then along the neo-spine-thalamic tract to
the thalamus, where another synapse occurs and then on to the
somatosensory cortex [26]. The neural stimulation must reach the
cortex in order to be perceived as pain.
For most types of acute pain, i.e. short-term pathology, such as
post-operative conditions, a broken bone, damaged ligaments or
tendons, burns, trauma, gunshot wounds, knife wounds, displaced
joints, etc., it is perfectly reasonable to use opioids to control
the acute pain. Narcotic (opioid) medications mimic the action
of naturally occurring enkephalin at the u1 and u2 morphine
receptors in the brain to give pain relief.
Narcotics work on enkephalin receptors in brain, gut,
spinal cord, heart, etc., such as K1 and K2, S1 and S2, which give
psychosis, respiratory depression, and low testosterone [27-
31]. Since one of the side effects of narcotics is euphoria and the
other is adaptation, which leads to withdrawal symptoms, these
medications are addicting. Part of this addiction mechanism is the
receptor site upregulation, so a patient needs more over time to
avoid withdrawal. Most acute pain can be controlled by narcotics, but
they are less useful in neuropathic (nerve) pain, and chronic pain.
Chronic Pain Anatomy and Pharmcology
Pain is the early warning system of the body. It tells the brain
something is wrong. The message of chronic pain is the result of
damage to tissue, and the damaged tissues send nerve signals
to the spinal cord. The pain message synapses in the spinal cord
and then travels to the brain using the palleo- or archio-spino
thalamic tract, with synapses in the reticular activating system, the
hypothalamus, the thalamus, and other structures. Then the pain
messages converge on the somatosensory cortex [32,33].
This multi-synaptic pathway involves areas of the brain which
control sleep and emotional features [34]. The chronic pain
pathway differs from the acute pain pathway in several ways. It is
a poly-synaptic pathway, and the pathway goes to different areas
in the brain than the acute pain pathway [35].
Different types of Tissue Damage
Another consideration often overlooked by clinicians is the
origin of pain. Various tissues, when damaged, produce pain. The
type of pain which is produced by a certain tissue is specific to that
tissue, and often can assist in diagnosis. The type of tissue damaged
retrospective analysis of these patients, pattern recognition, and
then prospective testing using predictive analytic techniques. The
Pain Validity Test could predict which patient would have medical
test abnormalities with 94% to 95% accuracy and could predict
which patients would not have any abnormalities with 85% to
100% accuracy [2-8]. These findings were independent of any
preexisting or co-existing psychiatric disorder. The Pain Validity
Test also has application in detecting drug seeking behavior or
identifying patients who are faking and malingering in order to
get opioids with 85%-100% accuracy [9]. The pain validity test is
available from www.MarylandClinicalDiagnostics.com.
Proper Diagnosis
A number of researchers have reported that 40% to 80%
of chronic pain patients are misdiagnosed [10-14]. Victims of
electrical shock are misdiagnosed 92% of the time, while patients
are mistakenly told they have fibromyalgia, 97% of the time
[15,16].
The Wall Street Journal cited 2013 research from a general
medical practice, which found that physicians missed 68 diagnoses
in 190 patients. The two major causes for this misdiagnosis rate
were 1) doctors didn’t take a complete medical history and 2) the
doctors ordered the wrong tests [17].
As an example of “the wrong test” Jensen et al reviewed lumbar
MRIs and found that 27 of 98 patients with no back pain, were told
they had protruding disc (28% false positive rate) [18]. In another
study, which compared 90 patients who had both an MRI and
provocative discograms, Braithwaite found that 77% of patients,
who had positive provocative discograms, had no changes in their
MRI [19]. A group from Cornell, led by Sandhu studied 53 patients
with severe neck pain using both MRI and provocative discograms.
In the patients who have pain with a provocative discogram,
79.5% had no MRI changes [20]. Likewise, Johns Hopkins Hospital
researchers showed that a regular CT missed pathology 56% of
the time, compared to a 3D-CT test [21]. Hendler and his group
studied patients with normal CT and MRI findings, who had been
misdiagnosed as “psychogenic pain patients” The 3-D CT found
pathology missed by the other two tests, and the diagnosis was
changed from a psychiatric one to a medical one [22].
Since the average physician spends only 11 minutes taking a
history from a patient, during which time he speaks 8 of the 11
minutes [23], it was apparent that a mechanism for obtaining
a more complete history was needed. Researchers from Johns
Hopkins Hospital developed an Internet based “expert system” for
chronic pain patients, which duplicate a physician taking a careful
and thorough history. The questionnaire consists of 72 questions,
with 2008 possible answers, which takes 45 to 60 minutes for a
patient to complete. The questionnaire, called the Diagnostic
Paradigm, which is available in either English or Spanish, at
www.MarylandClinicalDiagnostics.com, asks all the questions a
physician would ask, if he spent an hour taking a careful history.
Once the website is accessed, it takes only 5 minutes for
the staff member to set up a patient to take the test. After the
patient finishes the questionnaire, the answers are scored, using
a propriety scoring algorithm, which uses Bayesian logic. Within
five minutes, diagnoses with a 96% correlation with diagnoses of
Johns Hopkins Hospital doctors, are emailed to the treating doctor
[24]. The results also include the Treatment Algorithm, which
recommends the correct test to use for each diagnosis [14].
3. Page 3 of 5
Hendle N et al. Scimaze Anaesth Pain Management (2018) 1:101
Volume 1, Issue 1
Research ArticleOpen Access
do, which causes protective spasm, so the muscle doesn’t get
overstretched or ruptured. Stabilization of the excessive motion
is the treatment of choice in this instance.
1. Vascular Spasm: Vasospasm is the patho-physiological process
behind classic migraine headaches. Unfortunately, 35%-70% of
people told that they have migraine really have a mixed muscle
tension-vascular compression headache. So, drugs which work
on vasospasm will not be effective in these misdiagnosed
headaches. For the true migraine without aura (formerly
called common migraine), or migraine with aura (formerly
called classic or complicated migraine), vasoactive drugs like
Inderal, Nifedipine, or Imitrex relax the spasm. Raynauds is
another example of a disease which has vasospasm as the
basis of its pain production, and which responds to calcium
channel locking agents such as verapamil and nifedipine. Other
disorder such as Complex Regional Pain Syndrome (CRPS) has
vasoconstriction caused by over-excitement of the sympathetic
nerves, so that the vasoconstriction is a secondary result of
sympathetic stimulation. In this instance, an alpha1 sympathetic
inhibitor, such as Regitine is more appropriate than a vasoactive
drug. As in the case of migraine headache, 71%-80% of people
told they have CRPS actually have nerve entrapment, which
would respond better to an anti-convulsant [35,36]. Again, this
emphasizes the need for an accurate diagnosis before beginning
treatment.
2. Vascular Compression: There is really no pharmacological
basis to treatment for disorders like thoracic outlet syndrome.
Only mechanical decompression treats the underlying problem,
which has been advocated by a number of authors [37].
3. Vascular Inflammation: Temporal arteritis, or giant cell
arteritis is an inflammation which requires large doses of
steroids.
4. Acute Joint Inflammation and Chronic Joint Inflammation:
A number of drugs have anti-inflammatory activity or inhibit
prostaglandin synthesis. As a precautionary note, long-term or
large doses are both hepatotoxic and nephrotoxic. Salicylates
(e.g., aspirin) have antipyretic and analgesic effects as well as
anticoagulant and anti-inflammatory actions. Theoretically,
these actions result from the anti-prostaglandin activity, both
centrally and peripherally. Unfortunately, these additional
actions predispose this medication to produce gastritis and
serious gastrointestinal problems, including bleeding ulcer, in
susceptible individuals. Despite these problems, aspirin is still
the cheapest and most readily available analgesic preparation.
Nonsteroidal anti-inflammatory drugs (NSAIDs) have been
well reviewed by Klipper and Kolodny. They list nine major
categories. The most recent class of anti-inflammatory drugs is
called cyclooxygenases, or COX inhibitors.
5. Infection: Diagnosis of this cause of pain is the single most
important factor in treatment. Blood studies for sedimentation
rate, C-reactive protein, and white blood cell counts are not
adequate, since they miss the number of infections, including
abscesses, and biofilm. The use of Indium 111 scans, and
gallium scans augment the diagnostic process. Obviously, the
treatment is an appropriate antibiotic, or in some instances, the
use of several antibiotics simultaneously.
6. Acute Bone Pathology: Bone pain is very difficult to treat.
When a patient has a broken bone, the physician is certainly
determines the type of message of pain which is sent to the brain. If
a blood vessel is compressed, this can cause a throbbing pounding
pain, while if there is a viral infection affecting the small C fibers;
this causes a burning type of pain. It is important to ask the type
of pain, to assist in diagnosis, and to help select the appropriate
pharmacological agent.
Chronic Pain Anatomy and Pharmcology
Pain is the early warning system of the body. It tells the brain
something is wrong. The message of chronic pain is the result of
damage to tissue, and the damaged tissues send nerve signals
to the spinal cord. The pain message synapses in the spinal cord
and then travels to the brain using the palleo or archio-spino
thalamic tract, with synapses in the reticular activating system, the
hypothalamus, the thalamus, and other structures. Then the pain
messages converge on the somatosensory cortex [32,33].
The message of chronic pain is transmitted from peripheral
tissue damage, to the spinal cord, where a synapse occurs, and
then it travels along the palleo or archio-spino thalamic tract, with
synapses in the reticular activating system, the hypothalamus,
the thalamus, and then the pain messages converge on the
somatosensory cortex [32,33].
This multi-synaptic pathway involves areas of the brain which
control sleep and emotional features [34]. The chronic pain
pathway differs from the acute pain pathway in several ways. It is
a poly-synaptic pathway, and the pathway goes to different areas
in the brain than the acute pain pathway [35].
Different Types of Tissue Damage
Another consideration often overlooked by clinicians is the
origin of pain. Various tissues, when damaged, produce pain. The
type of pain which is produced by a certain tissue is specific to that
tissue, and often can assist in diagnosis. The type of tissue damaged
determines the type of message of pain which is sent to the brain. If
a blood vessel is compressed, this can cause a throbbing pounding
pain, while if there is a viral infection affecting the small C fibers;
this causes a burning type of pain. It is important to ask the type
of pain, to assist in diagnosis, and to help select the appropriate
pharmacological agent.
Inherent to understanding all pharmacological activity is the
understanding of the function of the synapse. The synapse affords
a physician one way of modifying the perception of pain. These
principles of synaptic modification can be applied to all aspects of
pain modification, for various types of tissue damage.
1) Primary Muscle Spasm: Primary muscle spasm occurs when
the striated muscle, which moves bones, is overstretched.
This is typically seen in sports injuries. A parallel
thread of actin and myosin constitutes muscle fibers called
actinomyosin. There are neurosynaptic receptors in the muscle,
which can be modified by muscle relaxing drugs like Zanaflex,
Flexeril, or Dantrolin, or at a spinal cord level using Baclofen, on
in the brain, like Diazepam, Baclofen and carisoprodol.
2) Secondary Muscle Spasm: This is the epiphenomenon which
is seen when ligaments, which hold bones in place, are torn,
and there is excessive movement between bones. At this
stage, treating the muscle spasm is a futile exercise, since the
pathology is the excessive movement, making the muscle fibers
do the work of ligaments, which they were not designed to
4. Page 4 of 5
Hendle N et al. Scimaze Anaesth Pain Management (2018) 1:101
Volume 1, Issue 1
Research ArticleOpen Access
justified in using narcotics. However, once the acute pain
process has subsided (4-6 weeks), if there is still bone pain,
then other sources, such as infection, mis-alignment, broken
hardware, etc. should be explored.
7. Ligament Damage: Ligaments hold bones together. The
acute phase, which should last no longer than 5-6 weeks,
can be managed with external bracing, narcotics, and anti-
inflammatory drugs. If pain with motion persists, then
ligamentous evulsion, occult fractures, and other sources for
pain need to be considered.
8. Nerve Compression: There is really no pharmacological basis
to treatment for disorders like ulnar nerve compression or
thoracic outlet syndrome. Only mechanical decompression
treats the underlying problem. However, anti-convulsants such
as Topamax and Lyrica may provide some relief until surgery.
This same rationale applies to radiculoipathies, due to neural
foraminal stenosis,
9. Nerve Irritation: Nerves can be irritated by entrapment,
inflammation, or infections, such as herpetic infections, seen
in herpes zoster or herpes simplex. A combination of anti-viral
drugs, steroids, and anti-convulsants is far more effective than
opioids or narcotics in the control of this pain.
The description of the type of pain may give important insight
into the type of tissue which is damaged, and thus allow more
rational selection of the type of medication best suited to control
the pain. A table summarizing the clinical features of damage to
various tissues is found below (Table 1).
Discussion
As Rhodes and his team have clearly documented, physicians
are spending less and less time with their patients [23]. This
truncated time leads to misdiagnosis, and the associated incorrect
treatmentofthesepatients[10-17].Thereducedtimewithapatient
has led to a less than thoughtful pharmacological management of
patients, with many doctors resorting to symptomatic treatment
of both acute and chronic pain using narcotics. Accurate diagnosis
improves the chance of identifying the type of tissue damage which
produces the clinical manifestation of chronic pain [22,24]. This is
best exemplified by the misdiagnosis rate of complex regional pain
syndrome (CRPS), where 71%-80% of the patients actually had
nerve entrapments. The correctly diagnosed nerve entrapments
would be best treated with anticonvulsants and eventually
peripheral nerve decompression, while the true CRPS patients
are best treated with alpha1 blocking agents, sympathetic blocks,
and eventually a sympathectomy. There is no role for narcotics for
either diagnosis. Therefore, as precision in diagnosis increases, so
should precision in pharmacological treatment [38,39].
Conclusion
There are many types of acute and chronic pain, caused by
a variety of tissue damage. By properly matching the correct
medication for the correct tissue damage, there is an increased
chance of improving control of chronic pain, without the need to
use opioids.
Acknowledgment:
Dr. Hendler has a financial interest in www.
MarylandClinicalDiagnostics.com
References
1. Weiner SG, Griggs CA, Mitchell PM, et al. Clinician impression versus
prescription drug monitoring program criteria in the assessment of
drug-seeking behavior in the emergency department. Ann Emerg Med
2013;62:281-289.
2. Hendler N, Viernstein M, Gucer P, et al. A preoperative screening test for
chronic back pain patients. Psychosomatics 1979;20:801-808.
3. Hendler N, Mollett A, Viernstein M, et al. A Comparison between
the MMPI and the ‘Mensana clinic back pain test’ for validating the
complaint of chronic back pain in women. Pain 1985; 23:243-251.
4. Hendler N, Mollett A, Viernstein M, et al. A comparison between the
MMPI and the ‘Hendler back pain test’ for validating the complaint of
chronic back pain in men. J of neurol & orthop med & surg 1985;6:333-337.
5. Hendler N, Mollett A, Talo S, et al. A comparison between the minnesota
multiphasic personality inventory and the ‘Mensana Clinic Back Pain
Test’ for validating the complaint of chronic back pain. J Occup Med
1988;30:98-102.
6. Hendler N, Cashen A, Hendler S, et al. A multi-center study for validating
the complaint of chronic back, neck and limb pain using “The mensana
clinic pain validity test”. Forensic Examiner 2005;14:41-49.
7. Hendler N, Baker A. An internet questionnaire to predict the presence
or absence of organic pathology in chronic back, neck and limb pain
patients. Pan Arab J Neuro surg 2008;12:15-24.
8. Hendler N. validating and treating the complaint of chronic back pain:
The mensana clinic approach. Clin Neuro surg 1989;35:385-397.
9. Hendler N. An internet-based questionnaire to identify drug seeking
behavior in a patient in the ed and office. J Anesth Crit Care Open Access
2017;8:00306.
10. Hendler N, Kozikowski J. Overlooked physical diagnoses in chronic pain
patients involved in litigation. Psychosomatics 1993;34:494-501.
Methods to Asses Pain
Burning Throbbing Sharp Dull Aching Spasm
Constant
This suggest nerve
irritation- chemical,
Metabolic, or viral
This suggest
vascular
compression-look
for the source of the
compression
This suggest
entrapment of
sensory nerves in
the skin
This suggest a
compression, tumor,
deep bruise or
infection get bone
scan
Deep achy pain
suggests bone bruise
or fracture get bone
scan
This suggest nerve
entrapment or
compression look
for the source of
compression
Intermittent
This would be
associated with
spasm of muscle or
blood vessel treat
those sources
This suggest
vascular spasm use
medications which
reduce spasm like
Imitrex
Seen in visceral
spasm such as
Crohn’s disease use
anti spasmotic
Pain only with use
sprain or strain due
to damage to tendon
or ligament
This suggest
inflammatory
process use non-
steroidal anti-
inflammatory drugs
This suggests muscle
spasm-use muscle
relaxants
Table 1: Type of pain associated with type of tissue damage.
Additionally, once the type of tissue damage is established, then the appropriate drugs within the categories mentioned above may be used.
5. Page 5 of 5
Hendle N et al. Scimaze Anaesth Pain Management (2018) 1:101
Volume 1, Issue 1
Research ArticleOpen Access
11. HendlerN,BergsonC,MorrisonC.Overlookedphysicaldiagnosesinchronic
pain patients in litigation, Part 2. Psychosomatics 1996;37:509-517.
12. Hendler N. Differential diagnosis of complex regional pain syndrome.
Pan Arab J Neuro surg 2002;6:1-9.
13. Dellon AL, Andronian E, Rosson GD. CRPS of the upper or lower
extremity: Surgical treatment outcomes. J Brachial Plex Peripher Nerve
Inj 2009;4:1.
14. Long D, Davis R, Speed W, et al. Fusion for occult post-traumatic cervical
facet injury. Neurosurg Q 2006;16:129-135.
15. Hendler N. Overlooked diagnoses in electric shock and lightning strike
survivors. J Occup Environ Med 2005;47:796-805.
16. Hendler N, Romano T. Fibromyalgia over-diagnosed 97% of the time:
Chronic pain due to thoracic outlet syndrome, acromo-clavicular joint
syndrome, disrupted disc, nerve entrapments, facet syndrome and
other disorders mistakenly called fibromyalgia. J Anesth Pain Med
2016;1:1-7.
17. Landro L. The wall street journal. 2013.
18. Jensen MC, Brant-Zawadzki MN, Obuchowski N, et al. Magnetic
resonance imaging of the lumbar spine in people without back pain. N
Engl J Med 1994;331:69-73.
19. Braithwaite I, White J, Saifuddin A, et al. Vertebral end-plate (Modic)
changes on lumbar spine MRI: correlation with pain reproduction at
lumbar discography. Eur Spine J 1998;7:363-368.
20. Sandhu HS, Sanchez-Caso LP, Parvataneni HK, et al. Association
between findings of provocative discography and vertebral endplate
signal changes as seen on MRI. J Spinal Disord 2000;13:438-443.
21. Zinreich SJ, Long DM, Davis R, et al. Three-dimensional CT imaging in
postsurgical “failed back” syndrome. J Comput Assist Tomogr 1990;14:
574-580.
22. Hendler N, Zinreich J, Kozikowski J. Three-dimensional CT validation
of physical complaints in “Psychogenic Pain Patients. Psychosomatics
1993;34:90-96.
23. Rhoades DR, McFarland KF, Finch WH, et al. Speaking and interruptions
during primary care office visits. Fam Med 2001;33: 528-532.
24. Hendler N, Berzoksky C, Davis RJ. Comparison of clinical diagnoses
versus computerized test diagnoses using the mensana clinic diagnostic
paradigm (expert system) for diagnosing chronic pain in the neck, back
and limbs. Pan Arab J Neuro surg 2007;6:8-10.
25. Landi A, Davis R, Hendler N, et al. Diagnoses from an on-line expert
system for chronic pain confirmed by intra-operative findings. J Anesth
Pain Med 2016;1:1-7.
26. Hendler N. The anatomy and psychopharmacology of chronic pain. The
J Clin Psych 1982;2:15-21.
27. Bethea CL, Reddy AP, Smith LJ. Nuclear factor kappa B in the dorsal
raphe of macaques: An anatomical link for steroids, cytokines and
serotonin. J Psychiatry Neurosci 2006;31:105-114.
28. Snyder S. The opiate receptor and morphine-like peptides in the
brain. Am J Psych 1978;135:645-652.
29. De Gregori S, De Gregori M, Ranzani GN, et al. Morphine metabolism,
transport and brain disposition. Metab Brain Dis 2012;27:1-5.
30. BoomM,NiestersM,SartonE,etal.Non-analgesiceffectsofopioids:Opioid-
induced respiratory depression. Curr Pharm Des 2012;18:5994-6004.
31. Castillo R, Kissin I, Bradley EL. Selective kappa opioid agonist for spinal
analgesia without the risk of respiratory depression. Anesth Analg
1986;65:350-354.
32. Kevetter GA, Willis WD. Collateralization in the spinothalamic tract:
New methodology to support or deny phylogenetic theories. Brain Res
1984;319:1-14.
33. Haefeli J, Kramer JL, Blum J, et al. Assessment of spinothalamic tract
function beyond pinprick in spinal cord lesions: A contact heat evoked
potential study. Neurorehabil Neural Repair 2014;28:494-503.
34. Jia Y, El-Haddad M, Gendy A, et al. Serotonin-induced region-specific
responses of the arcuate and ventromedial hypothalamic nuclei. Int J
Neurosci 2010;120:386-395.
35. DellonAL,HendlerN,HopkinsJETetal.Teammanagementofpatientswith
diffuse upper extremity complaints. Maryland Med J 1986;10:849-852.
36. Empting-Koschorke LD, Hendler, N, Kolodny AL, et al. Tips on hard-to-
manage pain syndromes. Patient Care 1990;24:26-46.
37. Klipper A, Kolodny AL. Non-steroidal anti-inflamatory drugs in
diagnosis and treatment of chronic pain, Edited by Nelson Hendler,
Donlin Long, Thomas Wise, 1982;183-192.
38. Pugely AJ, Bedard NA, Kalakoti P, et al. Opioid use following cervical
spine surgery: Trends and factors associated with long-term use. Spine
J 2018;18:30129-30133.
39. Jain N, Brock JL, Phillips FM, et al. Chronic preoperative opioid use is
a risk factor for increased complications, resource use, and costs after
cervical fusion. Spine J 2018:18:30126-30128.